Literature DB >> 8537643

Changes of MAP2 phosphorylation during brain development.

B M Riederer1, E Draberova, V Viklicky, P Draber.   

Abstract

The microtubule-associated protein MAP2 is essential for development of early neuronal morphology and maintenance of adult neuronal morphology. Several splice variants exist, MAP2a-d, with a lack of MAP2a in cat brain. MAP2 is widely used as a neuronal marker. In this study we compared five monoclonal antibodies (MAbs) against MAP2. They show differences in the immunocytochemical distribution of MAP2 isoforms during development of the visual cortex and cerebellum of the cat. Local and temporal differences were seen with MAb AP18, an antibody directed against a phosphorylation-dependent epitope near the N-terminal end. In large pyramidal dendrites in visual cortex, the AP18 epitope remained in parts immunoreactive after treatment with alkaline phosphatase. Three MAbs, AP14, MT-01, and MT-02, recognized the central region of the MAP2b molecule, which is not present in MAP2c and 2d, and reacted with phosphorylation-independent epitopes. During the first postnatal week the immunostaining in cerebellum differed between antibodies in that some cellular elements in external and internal granular layers and Purkinje cells were stained to various degrees, whereas at later stages staining patterns were similar. At early stages, antibody MT-02 stained cell bodies and dendrites in cerebral cortex and cerebellum. With progressing maturation, immunoreactivity became restricted to distal parts of apical dendrites of pyramidal cells and was absent from perikarya and finer proximal dendrites in cortex. MT-02 did not stain MAP2 in cerebellum of adult animals. This study demonstrates that the immunocytochemical detection of MAP2 depends on modifications such as phosphorylation and conformational changes of the molecule, and that MAP2 staining patterns differ between MAbs. Phosphorylation and specific conformations in the molecule may be essential for modulating function and molecular stability of MAP2, and monoclonal antibodies against such sites may provide tools for studying the functional role of modifications.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8537643     DOI: 10.1177/43.12.8537643

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  16 in total

1.  Distinct localization of a beta-tubulin epitope in the Tetrahymena thermophila and Paramecium caudatum cortex.

Authors:  L Libusová; T Sulimenko; V Sulimenko; R Janisch; P Hozák; P Dráber
Journal:  Protoplasma       Date:  2005-10-05       Impact factor: 3.356

2.  Trophic factor induction of human umbilical cord blood cells in vitro and in vivo.

Authors:  Ning Chen; Siddharth Kamath; Jennifer Newcomb; Jennifer Hudson; Svitlana Garbuzova-Davis; Paula Bickford; Cyndy Davis-Sanberg; Paul Sanberg; Tanja Zigova; Alison Willing
Journal:  J Neural Eng       Date:  2007-04-04       Impact factor: 5.379

3.  Emergence of activity-dependent, bidirectional control of microtubule-associated protein MAP2 phosphorylation during postnatal development.

Authors:  E M Quinlan; S Halpain
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

4.  Constitutively active cytoplasmic c-Jun N-terminal kinase 1 is a dominant regulator of dendritic architecture: role of microtubule-associated protein 2 as an effector.

Authors:  Benny Björkblom; Nina Ostman; Vesa Hongisto; Vladislav Komarovski; Jan-Jonas Filén; Tuula A Nyman; Tuula Kallunki; Michael J Courtney; Eleanor T Coffey
Journal:  J Neurosci       Date:  2005-07-06       Impact factor: 6.167

Review 5.  ReMAPping the microtubule landscape: How phosphorylation dictates the activities of microtubule-associated proteins.

Authors:  Amrita Ramkumar; Brigette Y Jong; Kassandra M Ori-McKenney
Journal:  Dev Dyn       Date:  2017-10-27       Impact factor: 3.780

Review 6.  TDP-43 and Cytoskeletal Proteins in ALS.

Authors:  Moritz Oberstadt; Joseph Claßen; Thomas Arendt; Max Holzer
Journal:  Mol Neurobiol       Date:  2017-05-02       Impact factor: 5.590

7.  Post-Translational Modifications During Brain Development.

Authors:  Bradley J Smith; Victor Corasolla Carregari
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

8.  Demyelinating and nondemyelinating strains of mouse hepatitis virus differ in their neural cell tropism.

Authors:  Jayasri Das Sarma; Kathryn Iacono; Lilli Gard; Ryan Marek; Lawrence C Kenyon; Michael Koval; Susan R Weiss
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

9.  Agomelatine (S20098) modulates the expression of cytoskeletal microtubular proteins, synaptic markers and BDNF in the rat hippocampus, amygdala and PFC.

Authors:  Nataly Ladurelle; Cecilia Gabriel; Adela Viggiano; Elisabeth Mocaër; Etienne E Baulieu; Massimiliano Bianchi
Journal:  Psychopharmacology (Berl)       Date:  2011-12-08       Impact factor: 4.530

10.  Elevating SOX2 levels deleteriously affects the growth of medulloblastoma and glioblastoma cells.

Authors:  Jesse L Cox; Phillip J Wilder; Michelle Desler; Angie Rizzino
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.